News
Real-Time Updates from Copper
News Center
Reco top In the Chongqing Ureteral Stent Alliance Volume-Based Procurement (VBP), Cooper Medical achieved Group A status across all categories and price points
Start of Autumn
Jinhua People’s Hospital has performed its first‑ever HIPEC treatment, opening up new hope for patients with abdominal cavity tumors
Soma Flowers Bloom, Dreams Set Sail | Cooper Soma Class Phase II Successfully Graduates
Soma Flowers Bloom, Dreams Set Sail | Cooper Soma Class Phase II Successfully Graduates
Literature Review I Important Evidence for Ovarian Cancer Treatment: Can HIPEC Combined with Surgery Bring Longer Survival Benefits?
Advanced ovarian cancer, especially in patients with extensive intraperitoneal dissemination, has long been a challenge in gynecologic oncology. Because ovarian cancer tends to implant and recur on the peritoneal surface, systemic therapy and surgery alone are sometimes insufficient to adequately control microscopic residual disease within the peritoneal cavity.
The 24 Solar Terms of China: Grain Buds
Special Review I Redefining the Treatment Paradigm for Peritoneal Metastases: The Clinical Value and Recent Advances of CRS + HIPEC
Peritoneal carcinomatosis has long been regarded as a hallmark of advanced progression in various solid tumors. Due to the widespread dissemination of tumor cells across the peritoneum, omentum, mesentery, and pelvic cavity, patients often present with ascites, bowel obstruction, and malnutrition. Traditional treatment has predominantly relied on palliative chemotherapy and supportive care, with overall prognosis remaining poor.
Copper Soma Class I Empowering Dreams, Sowing Hope in Daliangshan
This early summer, we received an unexpected and precious gift – from the children of the Copper Soma Class in the Daliangshan.
Good News | Cooper's New Ureteral Covered Stent System Approved for Market Launch